Company attributes
Industry
B2X
CEO
Legal Name
StrideBio, Inc.
Number of Employees (Ranges)
51 – 200
Full Address
PO Box 110321 Durham, NC 277090
5 Laboratory Drive Suite 1200, Research Triangle Park Durham, NC 27709 United States0
CIK Number
Investors
Founded Date
2015
Total Funding Amount (USD)
97,229,870
Latest Funding Round Date
March 2021
Former CEO
Latest Funding Type
Country
Other attributes
Company Operating Status
Active
Established in 2015, StrideBio, Inc. is a gene therapy company focused on creating and developing novel adeno-associated viral (AAV) vector technologies.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
